# Brightseed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/brightseed

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.brightseedbio.com
- Total disclosed funding: $95M
- Latest round: Series B (May 9, 2022)
- Investors on record: 6

## About

Based in California, US, and founded in 2017 by Jim Flatt, Lee Chae, and Sofia Elizondo, Brightseed, Inc. operates as a biotechnology company that uses artificial intelligence to map active compounds in plants and provide phytonutrient compound-based supplements for metabolic health. In May 2022, Brightseed, Inc. raised USD 68 million in series B funding led by Temasek Holdings, with participation from Lewis & Clark Venture, S2G Ventures, Continental Grain Company, Germin8 Ventures, and AgFunder Inc. 

Brightseed, Inc. is a creator of a technology platform for enhancing plant nutrients, with the goal of improving people's quality of life through natural means. The company's platform uses artificial intelligence to identify naturally occurring compounds with proven health and wellness benefits. The firm also focuses on rebalancing human metabolism and revealing the hidden potential of plants. This enables healthcare professionals to reduce the risks and effects of chronic illnesses while also empowering individuals to overcome health challenges.

## Funding rounds

- Series B, May 9, 2022, $68M — Temasek Holdings, Continental Grain Company, S2G Ventures, Lewis & Clark Ventures, AgFunder, Germin8 Ventures
- Series A, Sep 9, 2020, $27M — Lewis & Clark Ventures
- Seed, Jun 1, 2018 — AgFunder

## Investors

- AgFunder (https://capitalatlas.ai/funds/agfunder) — Seed, Series B
- Lewis & Clark Ventures (https://capitalatlas.ai/funds/lewis-clark-ventures) — Series A, Series B
- Temasek Holdings — Series B
- Continental Grain Company (https://capitalatlas.ai/funds/continental-grain-company) — Series B
- S2G Ventures (https://capitalatlas.ai/funds/s2g-ventures) — Series B
- Germin8 Ventures (https://capitalatlas.ai/funds/germin8-ventures) — Series B